Scott Andrew Smith's Net Worth
$6.04 Million
Who is Scott Andrew Smith?
Scott Andrew Smith has an estimated net worth of $6.04 Million. This is based on reported shares across multiple companies, which include BioAtla, Inc., Spring Bank Pharmaceuticals, Inc., Viatris Inc, Apexigen, Inc., TITAN PHARMACEUTICALS INC, and CELGENE CORP /DE/.
SEC CIK
Scott Andrew Smith's CIK is 0001614975
Past Insider Trading and Trends
2015 was Scott Andrew Smith's most active year for acquiring shares with 9 total transactions. Scott Andrew Smith's most active month to acquire stocks was the month of November. 2021 was Scott Andrew Smith's most active year for disposing of shares, totalling 19 transactions. Scott Andrew Smith's most active month to dispose stocks was the month of November. 2019 saw Scott Andrew Smith paying a total of $49,080.00 for 44,976 shares, this is the most they've acquired in one year. In 2021 Scott Andrew Smith cashed out on 45,201 shares for a total of $1,622,635.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BioAtla, Inc. (BCAB) Snapshot price: $2.7
Former President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.72% | -2.18K |
$1.37 | -$2,987.97 | 302.41K |
Jun 30
| |||
Form 4
| +5.73% | 16.5K |
—
|
—
| 304.59K |
Jun 13
| |||
Form 4
| -0.75% | -2.18K |
$1.51 | -$3,293.31 | 288.09K |
May 31
| |||
Form 4
| -0.75% | -2.18K |
$2.26 | -$4,929.06 | 290.27K |
Apr 30
| |||
Form 4
| -0.74% | -2.18K |
$3.44 | -$7,502.64 | 292.45K |
Mar 31
| |||
Form 4
| -0.73% | -2.18K |
$2.70 | -$5,888.70 | 294.64K |
Feb 29
| |||
Form 4
| -0.73% | -2.18K |
$1.92 | -$4,187.52 | 296.82K |
Jan 31
| |||
Form 4
| -0.60% | -1.79K |
$2.46 | -$4,405.86 | 299K |
Dec 31
| |||
Form 4
| -0.59% | -1.79K |
$1.77 | -$3,170.07 | 300.79K |
Nov 30
| |||
Form 4
| -0.59% | -1.79K |
$1.47 | -$2,632.77 | 302.58K |
Oct 31
| |||
Form 4
| -0.58% | -1.79K |
$1.70 | -$3,044.70 | 304.37K |
Sep 30
| |||
Form 4
| -0.58% | -1.79K |
$2.51 | -$4,495.41 | 306.16K |
Aug 31
| |||
Form 4
| -0.58% | -1.79K |
$2.99 | -$5,355.09 | 307.95K |
Jul 31
| |||
Form 4
| -0.57% | -1.79K |
$3.00 | -$5,373.00 | 309.74K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| -0.57% | -1.79K |
$3.15 | -$5,641.65 | 311.54K |
May 31
| |||
Form 4
| -0.57% | -1.79K |
$3.37 | -$6,035.67 | 313.33K |
Apr 30
| |||
Form 4
| -0.57% | -1.79K |
$2.68 | -$4,799.88 | 315.12K |
Mar 31
| |||
Form 4
| -0.56% | -1.79K |
$2.98 | -$5,337.18 | 316.91K |
Feb 10 - Feb 28
| |||
Form 4
| -0.68% | -2.18K |
$3.79 | -$8,265.99 | 318.7K |
Jan 31
| |||
Form 4
| -0.56% | -1.79K |
$8.25 | -$14,775.75 | 320.88K |
Dec 31
| |||
Form 4
| -0.55% | -1.79K |
$11.01 | -$19,718.91 | 322.67K |
Nov 30
| |||
Form 4
| -0.55% | -1.79K |
$6.89 | -$12,339.99 | 324.46K |
Oct 31
| |||
Form 4
| -0.55% | -1.79K |
$7.70 | -$13,790.70 | 326.25K |
Sep 30
| |||
Form 4
| -0.54% | -1.79K |
$8.71 | -$15,599.61 | 328.04K |
Aug 31
| |||
Form 4
| -0.54% | -1.79K |
$3.40 | -$6,089.40 | 329.83K |
Jul 31
| |||
Form 4
| -0.54% | -1.79K |
$2.85 | -$5,104.35 | 331.63K |
Jun 30
| |||
Form 4
| -0.53% | -1.79K |
$2.41 | -$4,316.31 | 333.42K |
May 31
| |||
Form 4
| -0.53% | -1.79K |
$3.48 | -$6,232.68 | 335.21K |
Apr 30
| |||
Form 4
| -0.53% | -1.79K |
$5.00 | -$8,955.00 | 337K |
Mar 31
| |||
Form 4
| -0.53% | -1.79K |
$6.48 | -$11,605.68 | 338.79K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| -0.64% | -2.18K |
$9.56 | -$20,850.36 | 340.58K |
Jan 31
| |||
Form 4
| -0.84% | -2.89K |
$19.63 | -$56,809.22 | 342.76K |
Dec 31
| |||
Form 4
| -1.17% | -4.09K |
$22.27 | -$91,099.33 | 345.66K |
Nov 30 - Dec 2
| |||
Form 4
| -0.11% | -399.00 |
$23.89 | -$9,532.11 | 349.75K |
Nov 29
| |||
Form 4
| -0.45% | -1.58K |
$25.26 | -$39,916.29 | 350.14K |
Nov 22 - Nov 24
| |||
Form 4
| -0.84% | -2.99K |
$30.18 | -$90,351.43 | 351.73K |
Oct 1
| |||
Form 4
| -8.57% | -33.24K |
$40.16 | -$1,334,926.93 | 354.72K |
Aug 26
| |||
Form 4
| +9.90% | 34.96K |
—
|
—
| 387.96K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spring Bank Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +50.05% | 12.5K |
—
|
—
| 37.48K |
Dec 31
| |||
Form 4
| +29.85% | 5.74K |
—
|
—
| 24.98K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
| +38.55% | 5.35K |
—
|
—
| 19.23K |
Jun 28
| |||
Form 4
| +637.28% | 12K |
$4.09 | $49,080.00 | 13.88K |
Jun 28
| |||
Form 4
|
∞
| 1.88K |
—
|
—
| 1.88K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viatris Inc (VTRS) Snapshot price: $11.89
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 85.35K |
$12.59 | -$697,196.43 | 85.35K |
Mar 3 - Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apexigen, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TITAN PHARMACEUTICALS INC (TTNP) Snapshot price: $6.426
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||